Skip to ContentSkip to Navigation
How to find us dr. O.W. Akkerman

Research interests

Pharmacokinetics and pharmacodynamics of anti TB drugs

Inhalation of antimicrobial drugs

Holistic approach of TB care


Outcome of treatment of MDR-TB or drug-resistant patients treated with bedaquiline and delamanid: Results from a large global cohort

Clinical and economic impact of medication non-adherence in drug-susceptible tuberculosis: a systematic review

Colistin dry powder inhalation with the Twincer (TM): An effective and more patient friendly alternative to nebulization

Corticosteroid therapy for the management of paradoxical inflammatory reaction in patients with pulmonary tuberculosis

Dose optimisation of first-line tuberculosis drugs using therapeutic drug monitoring in saliva: feasible for rifampicin, not for isoniazid

Eradication of Pseudomonas aeruginosa in cystic fibrosis patients with inhalation of dry powder tobramycin

Hope rises out of despair: bedaquiline and linezolid for the treatment of drug-resistant TB

Nationwide analysis of treatment outcomes in children and adolescents routinely treated for tuberculosis in The Netherlands

Patients and Medical Staff Attitudes Toward the Future Inclusion of eHealth in Tuberculosis Management: Perspectives From Six Countries Evaluated using a Qualitative Framework

Precision and Personalized Medicine and anti-TB treatment: Is TDM feasible for programmatic use?

Read more


Slim pillenpotje stimuleert therapietrouw patiënten met tuberculose

RTL EditieNL: Corona

Focus (NTR): Massale reisgedrag en tuberculose

Read more